India's No.1 Weekly For The Pharmaceutical Industry
About us || Feedback|| Advertising || Subscribe || Archives / Search 

-

Issue dated - 4th Dec. 2003

Latest News

[an error occurred while processing this directive]

News Archives >>
Themis to co-market Rofecoxib NDDS with two more companies
Indian cos stand a good chance of winning against Novartis: Natco
Shanta refutes GEAC charges on trial deaths
Dr Mashelkar has done his job; now, it’s the govt’s turn
INSIDE PHARMA
CLINICAL RESEARCH
RESEARCH
MARKETPLACE
EDITORIAL
OPED
CORPORATE
TECHNOLOGY
TRIPS
HEALTH NEWS
PRODUCTS
HAPPENINGS
CONVERSATION
MKT. RESEARCH - GLOBAL
BULK DRUGS MAKERS LIST
ESSENTIAL DRUGS LIST 
Pharma Research
(Adobe PDF file)

Advanced Search

CLINICAL RESEARCH
EDIT

Does a physician require EC clearance for clinical trials?
Can a physician conduct clinical trials for his own research, of a drug in indications, which are not approved by health authorities?

Editorial
Charity at home, after Africa
Edit Article
Medication error

RESEARCH
MARKETPLACE

Small-molecule inhibitors of botulinum neurotoxin identified
Scientists have identified several key molecules that block the activity of a toxin that causes botulism — an important first step in developing therapeutics to counter the disease.

Administrative marketing : Most important but ignored aspect
Administrative marketing gets the least attention because it involves back bending efforts, a lot of details to be looked into, writes C R Chenthir K
CORPORATE
TECHNOLOGY

AstraZeneca India launches new therapy for asthma
NPIL to introduce three biotech drugs from new partnership
Novartis’ anti-hypertensive Diovan has cardiac treatment potential: Study
Dabur Pharma eyes foray into cancer diagnostic services

More >>

MDS, Iconix introduce Pharmotif solutions for chemogenomics profiling
Pressure filtration using the BHS Autopress technology
Kodak to acquire Algotec to consolidate position in PACS market

HEALTH NEWS

HAPPENINGS
76 per cent private abortion centres are unregistered: Study
India close to achieving leprosy elimination
Agilent appoints Ludwig Huber as compliance fellow for life sciences biz
AT A GLANC
CP Kelco organises seminar on gels and solutions
CONVERSATION
TRIPS

‘Industry should avoid duplication of research’
Dr Dinesh S Patel, managing director and CEO of the three-decades old Themis Medicare Ltd, is steering the company’s research and development efforts and says he is impatient for the product patent era to dawn.

Competitive environment post 2005
Patents to protect innovation could be supported, but the system should not be a device to restrict competition and allow creation of monopolies under any circumstances, says B K Keayla in the concluding part of the article

For
JOB OPTIONS

Click here

 


<Top of page>
ABOUT US FEEDBACK ADVERTISE SUBSCRIBE ARCHIVES
 


© Copyright 2000: Indian Express Group (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by
The Business Publications Division of the Indian Express Group of Newspapers. Please contact our Webmaster for any queries on this site.